DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release03-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201531-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201530-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificate(s)29-12-2023
Dr. Reddy's acquires 6.46% stake in Edity Therapeutics
Therapeutics based on the Edity technology could be useful in multiple therapeutic areas, including gene editing, rare genetic disorders29-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Sanjiv Mehta as an Additional Director, categorized as Independent, on the Board of the Company.29-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of securities by a wholly-owned step-down subsidiary company29-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of newspaper publication23-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of share certificate intimation22-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Closure of Trading Window
Closure of Trading Window21-12-2023